• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CDT Equity Inc. - Common Stock (NQ:CDT)

1.400 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about CDT Equity Inc. - Common Stock

< Previous 1 2 Next >
News headline image
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy
January 02, 2026
Engagement reinforces CDT’s strategy to unlock value from its solid-form asset portfolio 
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Increases Bitcoin Holding
October 17, 2025
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Inc. Announces Reverse Stock Split
October 09, 2025
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Executes Cryptocurrency Treasury Reserve Strategy
September 17, 2025
Initial digital asset acquisition marks milestone in capital diversification initiative 
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve Strategy
September 03, 2025
Cryptocurrency treasury reserve strategy is designed to diversify capital structure while reinforcing CDT's innovation-led model 
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
August 26, 2025
Using AI, CDT Equity Inc. identifies a novel therapeutic indication for its lead programmes, supported by successful pre-clinical trial data 
From CDT Equity Inc.
Via GlobeNewswire
News headline image
Conduit to Change Name to CDT Equity Inc.
August 05, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy
July 08, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
July 07, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health
June 04, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
May 22, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
May 21, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
May 16, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
May 09, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset
May 08, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Announces Leadership Changes
April 16, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects
April 11, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program
April 10, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
April 07, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
March 31, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904
March 19, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
March 06, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Progresses Phase II of its AI Initiative with Sarborg
February 20, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
February 13, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note
February 11, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
February 07, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
January 28, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 23, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
January 22, 2025
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
December 12, 2024
From Conduit Pharmaceuticals
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap